Brenton Taylor - 01 Sep 2021 Form 4 Insider Report for Inogen Inc (INGN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
03 Sep 2021, 16:33:41 UTC
Prior SEC filing
29 Jul 2021
Next SEC filing
30 Sep 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Alison Bauerlein, as Attorney-in-Fact

Key filing fact

Brenton Taylor filed Form 4 for Inogen Inc (INGN) on 03 Sep 2021.

Key facts

  • This page summarizes Brenton Taylor's Form 4 filing for Inogen Inc (INGN).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Sep 2021, 16:33.

Change

  • Previous filing in this sequence was filed on 29 Jul 2021.
  • Current net transaction value: -$20,897.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INGN transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+273
Change %
+0.48%
Price
$0.000000
Shares after
57,135
Date
01 Sep 2021
Ownership
Direct
INGN transaction

Common Stock

Tax liability

Transaction value
$20,897
Shares
-345
Change %
-0.6%
Price
$60.57
Shares after
56,790
Date
01 Sep 2021
Ownership
Direct
Footnotes
F1
INGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
842
Date
01 Sep 2021
Ownership
By Spouse

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INGN transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-273
Change %
-9.1%
Price
$0.000000
Shares after
2,730
Date
01 Sep 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
273
Exercise price
Footnotes
F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2021.

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.

Footnote F3

Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .